Old and new drugs in systemic therapy of pancreatic cancer

Author： Pasetto L.M. Jirillo A. Stefani M. Monfardini S.

Publisher： Elsevier

ISSN： 1040-8428

Source： Critical Reviews in Oncology/Hematology, Vol.49, Iss.2, 2004-02, pp. : 135-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

New Techniques and Agents in the Adjuvant Therapy of Pancreatic Cancer

By Raraty Michael G. T. Magee Conor J. Ghaneh Paula Neoptolemos John P.

Acta Oncologica, Vol. 41, Iss. 7-8, 2002-11 ,pp. : 582-595

Informa Healthcare

Access to resources Recommend Favorite

Ovarian Cancer--New Insights into Systemic Therapy

By Neijt J.P.

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 823-824

Elsevier

Access to resources Recommend Favorite

New trends in primary systemic therapy for breast cancer

By Horiguchi Jun

Breast Cancer, Vol. 18, Iss. 2, 2011-04 ,pp. : 73-73

Springer Publishing Company

Access to resources Recommend Favorite

Borderline Resectable Pancreatic Cancer: A New Classification for an Old Challenge

By Talamonti Mark

Annals of Surgical Oncology, Vol. 13, Iss. 8, 2006-08 ,pp. : 1019-1020

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant Therapy in Pancreatic Cancer

By Quiros Roderick M. Brown Kimberly M. Hoffman John P.

Cancer Investigation, Vol. 25, Iss. 4, 2007-06 ,pp. : 267-273

Informa Healthcare

Access to resources Recommend Favorite